Director Shareholding
November 20 2003 - 10:00AM
UK Regulatory
RNS Number:3111S
AstraZeneca PLC
20 November 2003
DEALING BY DIRECTORS
COMPANIES ACT 1985 SECTION 324/329
WE HEREBY INFORM YOU THAT, ON 19 NOVEMBER 2003, WE WERE NOTIFIED BY DR H L
MOGREN, A DIRECTOR OF THE COMPANY, THAT, ON 19 NOVEMBER 2003, HE SOLD 6,535
OPTIONS OVER ASTRAZENECA PLC ORDINARY SHARES OF USD0.25 EACH.
THESE OPTIONS WERE ORIGINALLY GRANTED TO DR MOGREN IN 1997 OVER SHARES IN ASTRA
AB UNDER THE ASTRA SHAREHOLDER VALUE INCENTIVE PLAN. THE OPTIONS WERE
SUBSEQUENTLY CONVERTED INTO OPTIONS OVER ORDINARY SHARES IN ASTRAZENECA PLC IN
APRIL 1999. DETAILS OF THE UNDERLYING ASTRAZENECA SHARES OVER WHICH THE OPTIONS
WERE HELD ARE AS FOLLOWS:-
NUMBER OF ASTRAZENECA EFFECTIVE OPTION MARKET PRICE OF
SHARES OVER PRICE PER ASTRAZENECA SHARES WHEN
WHICH OPTIONS WERE HELD SHARE OPTIONS WERE SOLD
8,792 316.13SEK 358SEK
FOLLOWING THIS TRANSACTION, DR MOGREN HOLDS OPTIONS OVER 261,184 ORDINARY SHARES
OF ASTRAZENECA PLC.
G H R MUSKER
COMPANY SECRETARY
20 NOVEMBER 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBSBDBBXDGGXG